Synthorx
Synthetic biology company that created novel DNA base pairs and uses them to incorporate novel amino acids into proteins for potential therapeutics in areas of cancer and autoimmune disorders.
5
Funding Rounds
$152.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| Fl*** Ro******* | - | - | - |
Funding
Funding series
Funding Series Analysis
The company Synthorx has raised a total of $73m in funding over 5 rounds.
Key Insights:
- Synthorx Series C round, April 2018: $63m
- Synthorx Series B round, July 2016: $10m
- Synthorx Series B Funding Round July 2016: $10m
- Synthorx Series C Funding Round April 2018: $63m
- Synthorx Series A Funding Round April 2014: $6m
Synthorx Series C round, April 2018
$63m
Synthorx Series B round, July 2016
$10m
Synthorx Series A Funding Round April 2014
$6m
Synthorx Series B Funding Round July 2016
$10m
Synthorx Series C Funding Round April 2018
$63m
Industries
Synthorx is active in the following industries: